Last Update 23:22
Tuesday, 22 June 2021

EU to get 107 million COVID doses by end of March, 30 mln from AstraZeneca

Pfizer-BioNTech will deliver 67.5 million doses and Moderna nearly 10 million, figures that the EU has said are in line with their initial commitments

Reuters , Wednesday 31 Mar 2021
AstraZeneca
This file photo taken on March 11, 2021 shows vials of the AstraZeneca Covid-19 vaccine in Paris. - Experts probing links between the AstraZeneca coronavirus vaccine and blood clots have found no specific risk factors, including age, but are carrying out further analysis, the EU's drug regulator said on March 31, 2021. AFP
Share/Bookmark
Share/Bookmark

European Union states are expected to receive 107 million doses of COVID-19 vaccines by the end of March, an EU Commission spokeswoman said on Wednesday, hitting an earlier target but far below initial plans.

Under contracts signed with drugmakers, the bloc had expected to receive 120 million doses by the end of March from Anglo-Swedish firm AstraZeneca alone and tens of millions more doses from Pfizer-BioNTech and Moderna.

But after major cuts from AstraZeneca, the EU had revised down its target until the end of March to about 100 million doses.

The Commission spokeswoman told a news conference that AstraZeneca was expected to deliver 29.8 million doses by Wednesday, in line with its revised-down goal.

Pfizer-BioNTech will deliver 67.5 million doses and Moderna nearly 10 million, figures that the EU has said are in line with their initial commitments.

The EU expects a major ramp-up of deliveries in the second quarter that it says will be sufficient to inoculate at least 70% of its adult population by July, and speed up its so far slow vaccination drive.

Short link:

 

Latest

© 2010 Ahram Online.